Historically, annual M&A activity peaks at year-end as buyers and sellers rush to close before the end of the tax year. However, in 2022, the market took an extended intermission… Read more »
Amidst public market volatility and economic uncertainty, private capital investment funds remain open for business, albeit with increased scrutiny and rigorous diligence on every deal. Issuers, lenders and sponsors are… Read more »
Beauty Care M&A volume has officially rebounded to pre-pandemic levels with 30 transactions in Q2’21. Such levels represent a 3.4% increase over Q1’21, a whopping 50% increase over pandemic ravaged… Read more »
Industry Report
Private equity and strategic buyers spent more than $1.7 trillion on mergers and acquisitions involving U.S. companies during the first six months of the year – the highest amount in… Read more »
Ed Bagdasarian, CEO of Intrepid, recently participated in the CFO & CEO Leadership panel alongside other leading CEOs who discussed how companies could remain resilient and plan for growth in… Read more »
M&A and investment activity in the urology sector has gained momentum over the past five years. Since Audax Group’s initial investment in Chesapeake Urology in August 2016, highly experienced multi-site… Read more »
Webinar
While our team unfortunately could not visit universities this spring as originally planned, the recruitment of bright Analysts and Summer Analysts remains core to supporting our continued growth as a… Read more »
At Intrepid, we help clients win big. We know what’s at stake. Our bankers understand that the value of a company lies in the magic of its culture and innovative spirit…. Read more »
Analysts are key members of Intrepid’s deal teams. We look for talented, motivated individuals who want to make a difference and do a lot more than build spreadsheets. From day… Read more »